TrialThe oncologist2019

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.

Jaydira Del Rivero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.